Carter, B. Z., Mak, P. Y., Mak, D. H., Ruvolo, V. R., Schober, W., McQueen, T., . . . Andreeff, M. (2015). Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34(+) proliferating and quiescent chronic myeloid leukemia blast crisis cells. Oncotarget.
Chicago Style citaatCarter, Bing Z., et al. "Synergistic Effects of P53 Activation Via MDM2 Inhibition in Combination With Inhibition of Bcl-2 or Bcr-Abl in CD34(+) Proliferating and Quiescent Chronic Myeloid Leukemia Blast Crisis Cells." Oncotarget 2015.
MLA citatieCarter, Bing Z., et al. "Synergistic Effects of P53 Activation Via MDM2 Inhibition in Combination With Inhibition of Bcl-2 or Bcr-Abl in CD34(+) Proliferating and Quiescent Chronic Myeloid Leukemia Blast Crisis Cells." Oncotarget 2015.